Parkin exerts the tumor-suppressive effect through targeting mitochondria.

The role of PARKIN in Parkinson's disease is well established but its role in cancer has recently emerged. PARKIN serves as a tumor suppressor in many cancers and loses the tumor-suppressive function due to loss of heterozygosity and DNA copy number. But how PARKIN protects against cancer is poorly understood. Through the analysis of PARKIN substrates and their association with mitochondria, this viewpoint discussed that PARKIN exerts its anti-cancer activity through targeting mitochondria. Mitochondria function as a convergence point for many signaling pathways and biological processes, including apoptosis, cell cycle, mitophagy, energy metabolism, oxidative stress, calcium homeostasis, inflammation, and so forth. PARKIN participates in these processes through regulating its mitochondrial targets. Conversely, these mitochondrial substrates also influence the function of PARKIN under different cellular circumstances. We believe that future studies in this area may lead to novel therapeutic targets and strategies for cancer therapy. © 2023 Wiley Periodicals LLC.

Citation

Xin Sun, Guiqin Ye, Yuanyuan Mai, Yuhan Shu, Lei Wang, Jianbin Zhang. Parkin exerts the tumor-suppressive effect through targeting mitochondria. Medicinal research reviews. 2023 Jul;43(4):855-871

Mesh Tags

Substances

PMID: 36916678

search → result